TTK HealthcareShare Price Today (TTKHLTCARE)
Today’s TTK Stock Read
TTK Healthcare (TTKHLTCARE) share price is trading at ₹922.75, down 0.05% today. The stock opened at ₹929.95, touched an intraday high of ₹922.75 and low of ₹922.75. It is currently near key moving averages, with a P/E of 20.01, ROE of 6.03 %, and a market cap of ₹1,285.15 Cr. Track live NSE/BSE price, chart, valuation, financials, technical indicators, delivery volume, peers and latest filings on StockeZee before taking a trading or investment view.
Today’s TTK Stock Read
TTK Healthcare (TTKHLTCARE) share price is trading at ₹922.75, down 0.05% today. The stock opened at ₹929.95, touched an intraday high of ₹922.75 and low of ₹922.75. It is currently near key moving averages, with a P/E of 20.01, ROE of 6.03 %, and a market cap of ₹1,285.15 Cr. Track live NSE/BSE price, chart, valuation, financials, technical indicators, delivery volume, peers and latest filings on StockeZee before taking a trading or investment view.
TTK Healthcare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for TTK Healthcare Limited, framed against the sector median so the premium or discount is obvious at a glance.
TTK Healthcare Limited trades at a P/E of 20.01× and P/B of 1.18×.
Valuation
Profitability
Growth
Financial Health
TTK Healthcare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for TTK Healthcare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
TTK Healthcare Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for TTK Healthcare Limited, switchable between annual and quarterly views, consolidated or standalone.
TTK Healthcare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,285.15 Cr and reported EPS of ₹46.49.
TTK Healthcare segment analysis: revenue and profit mix.
Disclosed business segments at TTK Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
TTK Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for TTK Healthcare Limited.
Our AI distills the core fundamental drivers supporting TTK Healthcare Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
TTK Healthcare Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
High promoter holding of 74.6% indicates strong insider confidence and stability.
Very low debt-to-equity ratio of 0.02 signifies a healthy financial structure.
Attractive P/E ratio of 24.02 is below the sector average.
Strong 5-year EPS growth at 45.91% demonstrates consistent profitability.
Diversified business model across multiple sectors provides inherent operational resilience.
What can break it.
Significant quarterly net profit volatility raises concerns about stable profitability.
Low Return on Equity (ROE) of 3.40% indicates inefficient capital utilization.
Operating Profit Margin (OPM) of 1.60% is relatively low, suggesting operational inefficiencies.
Negative annual cash flow per share (-11.90) signals liquidity challenges.
Declining institutional interest (FII, DII) indicates potential loss of investor confidence.
What would change my mind.
Trim if P/E re-rates above 26. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
TTK Healthcare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — TTK Healthcare Limited is highlighted for quick read-across.
Quick Compare
TTK Healthcare Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for TTK Healthcare Limited — derived from the live tape, not yesterday's close.
TTK Healthcare Limited last traded at ₹922.75 with an intraday range of ₹909.5–₹944 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹922.75| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1010.33 | +87.58 | +9.49% |
| R3 | 975.83 | +53.08 | +5.75% |
| R2 | 959.92 | +37.17 | +4.03% |
| R1 | 941.33 | +18.58 | +2.01% |
| PIVOT | 925.42 | 2.67 | 0.29% |
| CURRENT | 922.75 | — | — |
| S1 | 837.83 | -84.92 | -9.20% |
| S2 | 872.33 | -50.42 | -5.46% |
| S3 | 890.92 | -31.83 | -3.45% |
| S4 | 906.83 | -15.92 | -1.72% |
TTKHLTCARE is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 929.95 ~ 943.65
Trading Inside opening range
TTK Healthcare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for TTK Healthcare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in TTK Healthcare Limited stood at 62.8% of traded volume, against a 20-day average of 62.4%.
TTK Healthcare announcements: results, concalls, ratings, M&A.
Filings TTK Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
TTK Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 65 documents below.
Disclosure under SEBI Takeover Regulations
TTK Prestige Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Record Date
TTK Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Jul-2026.
Outcome of Board Meeting
TTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
TTK Healthcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue TTK Healthcare has declared, sequenced by announce and record date.
TTK Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About TTK Healthcare Limited: business, sector, key facts.
What TTK Healthcare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
TTK Healthcare Limited operates in the Diversified industry under the Diversified sector, listed as NSE: TTKHLTCARE, BSE: 507747.
TTK Healthcare Limited is a diversified Indian company operating across various sectors, including animal welfare, consumer products, medical devices, protective devices, food, and human pharmaceuticals. Its business model is segmented, allowing for focused growth and management within each area.
In the animal welfare segment, TTK Healthcare provides a comprehensive range of products for veterinarians and farmers, encompassing feed supplements, medications addressing various health concerns (liver support, fertility, infections, parasites), and specialized products for different animal types (dairy, poultry, aqua, pets). This signifies a substantial commitment to the animal health market in India.
The consumer products division markets and distributes a variety of goods under several well-established brand names. These include baby care products (Woodward's Gripewater), personal care and cosmetics (EVA), home care items (Good Home), and air fresheners, demonstrating a broad appeal to a large consumer base across various demographics.
Within the medical devices sector, TTK Healthcare is a significant player, notably producing and distributing artificial heart valves (TTK Chitra) and orthopedic implants and instruments crucial for knee and hip replacement surgeries. This high-value segment positions the company as a key contributor to India's healthcare infrastructure.
The protective devices segment focuses on sexual wellness products, including male contraceptives under the Skore brand. This specialization reveals a dedication to offering specific and important health solutions.
The foods division manufactures and markets food products such as papads (Fryums) and a range of cereal, potato, rice, pulse, and corn-based products. This broad portfolio taps into the everyday needs of a large portion of the Indian population.
In the human pharmaceuticals area, TTK Healthcare develops and commercializes medicines targeting various therapeutic areas, including gynecology, infertility, respiratory issues, orthopedics, cardiology, and general health. This reflects a dedication to addressing diverse healthcare requirements across a wide range of patient needs.
Finally, the 'Others' segment encompasses the printing and publishing of maps, atlases, guidebooks, and educational materials under the TTK brand. While distinct from the other segments, it showcases a diversification strategy beyond healthcare and related fields.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3M India (3MINDIA) Share PricePeer
- Balmer Lawrie & Company (BALMLAWRIE) Share PricePeer
- DCM Shriram (DCMSHRIRAM) Share PricePeer
- Dhunseri Ventures (DVL) Share PricePeer
- Godrej Industries (GODREJIND) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about TTK Healthcare Limited (TTKHLTCARE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of TTK Healthcare Limited (TTKHLTCARE)?
The current share price of TTK Healthcare Limited (TTKHLTCARE) is ₹922.75. Today, the stock has declined by ₹0.50 (0.05%), trading in a range of ₹909.5 to ₹944. The stock opened at ₹929.95 with a trading volume of 1,345 shares.
02Is TTK Healthcare Limited stock a good investment for long-term?
TTK Healthcare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,285.15 crores, P/E ratio of 20.01, ROE of 6.03%, and ROCE of 8.04%. The dividend yield stands at 1.08%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of TTK Healthcare Limited stock?
The 52-week high price of TTK Healthcare Limited (TTKHLTCARE) is ₹1,398.9, while the 52-week low is ₹735. Currently trading at ₹922.75, the stock is 28.3% away from its 52-week low and 34.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy TTK Healthcare Limited stock at the current price?
Whether to buy TTK Healthcare Limited stock at ₹922.75 depends on multiple factors. The stock is currently trading with a P/E ratio of 20.01 and P/B ratio of 1.18. Today's performance shows a loss of 0.05%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of TTK Healthcare Limited and when is the next dividend?
TTK Healthcare Limited offers a dividend yield of 1.08%, which means for every ₹100 invested at the current price of ₹922.75, you can expect to receive approximately ₹1.08 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of TTK Healthcare Limited?
TTK Healthcare Limited's key financial metrics include: P/E Ratio: 20.01, P/B Ratio: 1.18, ROE: 6.03%, ROCE: 8.04%, Dividend Yield: 1.08%, EPS: ₹46.49, Book Value: ₹788.93, and Debt-to-Equity: 0.02. The company's market cap stands at ₹1,285.15 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is TTK Healthcare Limited stock performing today in the market?
TTK Healthcare Limited stock opened at ₹929.95 and is currently trading at ₹922.75, showing a decline of ₹0.50 (0.05%). The intraday high is ₹944 and low is ₹909.5. The trading volume stands at 1,345 shares, indicating moderate market participation today.
08What is the P/E ratio of TTK Healthcare Limited and what does it indicate?
TTK Healthcare Limited has a Price-to-Earnings (P/E) ratio of 20.01, which means investors are willing to pay ₹20.01 for every ₹1 of earnings. With an EPS of ₹46.49, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about TTK Healthcare Limited (TTKHLTCARE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.